Study Objectives: The assessment of pharyngeal collapsibility is difficult to perform in children under normal sleep. An alternative is to perform the assessment under an anesthetic, such as dexmedetomidine (DEX), that induces non-rapid eye movement (NREM) sleep. The objectives of this study were to compare critical closing airway pressure (Pcrit) obtained during natural sleep to that obtained under DEX in patients with Down syndrome (DS) and persistent obstructive sleep apnea (OSA) and determine whether Pcrit measured under sedation predicts the severity of OSA. Methods: The passive and active Pcrit, which represent airway passive mechanical properties and active dynamic responses to airway obstruction, respectively, were measured. Upper airway reflex activity was estimated by calculating the difference between active and passive Pcrit. Subjects underwent overnight polysomnography during which Pcrit was measured during normal sleep. Pcrit was also measured during DEX sedation at a dose of 2 µg/kg/h. Results: The study included 50 patients with median age of 11.4 years (interquartile range: 7.0-13.9) and median body mass index of 23.0 kg/m 2 (interquartile range: 18.4-29.1), 66% male and 80% Caucasian. Passive Pcrit was significantly higher than active Pcrit when measured during normal sleep and DEX-induced sleep. There was a positive association between apnea-hypopnea index and passive Pcrit (Spearman r = 0.53, P = .0001) and active Pcrit (r = 0.55, P = .0002) under DEX-induced sleep. There were no significant differences between the Pcrit measurements during natural sleep and during DEX sedation.
I NTRO DUCTI O NObstructive sleep apnea (OSA) is increasingly recognized as a common disorder in children. It is characterized by recurrent partial or total collapse of the upper airway 1 and is associated with cognitive, metabolic, and cardiovascular morbidity. Children with OSA respond well to adenotonsillectomy (T&A) as a first-line treatment. However, a large percentage of children have recurrence of OSA several months after T&A. In one study, 27% of lean children and 79% of obese children without genetic syndromes had recurrences of OSA 1 year after T&A.3 In children with genetic syndromes and craniofacial abnormalities, OSA either persists or recurs in a much larger percentage of children.4 A significant proportion of children with Down syndrome (DS) may have persistent or recurrent OSA after T&A. Prior to repeat interventions, clinicians must identify the level(s) of residual obstruction. This is often accomplished through examination of the patterns of dynamic airway collapse during sedation-induced sleep. properties that parallel the physiologic changes seen during nonrapid eye movement sleep through action on alpha 2-adrenergic receptors. These properties make dexmedetomidine an attractive drug for sedating children who need dynamic upper airway evaluation. Study Impact: The responses to airway obstruction and the association between airway collapsibility and obstructive sleep apnea severity during dexmedet...